Preetam Shah

Chief Financial Officer, BRAINSTORM CELL THERAPEUTICS INC.

Companies

Elicio Therapeutics, Inc.Officer Apr 2, 2025 to now¹
Cidara TherapeuticsChief financial officer Sep 3, 2021 to Feb 26, 2025²
BRAINSTORM CELL THERAPEUTICS INC.Chief financial officer Sep 9, 2019 to Dec 31, 2020³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 2, 2026Granted 24,000 shares of Elicio Therapeutics, Inc.⁴
Mar 15, 2024Granted 108,750 shares of Cidara Therapeutics⁵
Mar 11, 2024Sold 18,931 shares at $0.67 of Cidara Therapeutics⁶
Mar 27, 2023Granted 90,000 shares of Cidara Therapeutics⁷
Mar 13, 2023Sold 6,648 shares at $1.53 of Cidara Therapeutics⁸
Sep 19, 2022Sold 15,642 shares at $0.77 of Cidara Therapeutics⁹
Sep 15, 2022Exercised options 50,000 shares of Cidara Therapeutics⁹
Mar 31, 2022Shares withheld for tax 24,820 shares at $0.83 of Cidara Therapeutics¹⁰
Mar 31, 2022Granted 66,001 shares of Cidara Therapeutics¹⁰
Mar 31, 2022Granted 51,250 shares of Cidara Therapeutics¹⁰
Nov 12, 2021Bought 20,000 shares at $1.54 of Cidara Therapeutics¹¹

The numbers on this page point here. Each one links to the record it came from.